Wróć do słownika

Healthcare professional (HCP) research

HCP research, also known as healthcare professional research, examines the knowledge, attitudes, clinical decision-making and unmet needs of medical professionals. It provides evidence for pharmaceutical, medtech, diagnostics and healthcare organisations that need to understand how products, services or treatment pathways are evaluated and used in real clinical practice.

What is healthcare professional (HCP) research?

Healthcare professional (HCP) research is a branch of market research focused on people who deliver, influence or support healthcare. Depending on the study objective, respondents may include physicians, nurses, pharmacists, dentists, laboratory specialists and other healthcare decision-makers. Broader healthcare stakeholder research may also include hospital procurement staff, payers, clinic managers and other non-clinical decision-makers. The scope is defined by the role an individual plays in diagnosis, treatment, prescribing, recommending, purchasing, dispensing or administering a health-related product or service.

In market research, HCP research is used to translate professional experience and clinical behaviour into actionable evidence. It can examine how healthcare professionals diagnose a condition, select treatments, interpret clinical data, perceive a brand, adopt a medical device or navigate organisational constraints. Its purpose is not to replace clinical research. Rather, it explains the market and behavioural context in which clinical evidence, commercial communication and healthcare solutions are received.

The term healthcare professional research commonly covers several analytical areas:

  • awareness and perception of therapeutic areas, brands, technologies or service providers;
  • patient journey and clinical pathway mapping;
  • treatment selection, prescribing, switching and referral behaviours;
  • unmet needs in diagnosis, treatment, monitoring or healthcare delivery;
  • evaluation of product concepts, value propositions, claims and educational materials;
  • assessment of access barriers, formulary restrictions, procurement processes and institutional requirements;
  • segmentation of HCPs based on attitudes, behaviour, practice setting or decision-making role.


The defining feature of HCP research is the need to interpret answers in the context of professional responsibility and healthcare system realities. A physician may value a therapy clinically but encounter reimbursement restrictions. A nurse may be central to treatment adherence but not make prescribing decisions. A hospital pharmacist may influence formulary access without interacting directly with patients. Good research design therefore distinguishes between clinical influence, economic influence and formal purchasing authority.

Application of healthcare professional (HCP) research in practice

HCP research is used throughout the lifecycle of pharmaceutical products, medical devices, diagnostic tests, digital health solutions and healthcare services. It supports decisions made by product managers, medical affairs teams, market access specialists, marketers, researchers and commercial leaders. The appropriate approach depends on whether the organisation needs to measure prevalence, understand motivation or connect both types of evidence.

Before launch, healthcare professional research can identify gaps in current care, validate the relevance of a product concept and assess the clarity of proposed positioning. For example, in a diagnostics project, interviews with laboratory directors and specialists may reveal whether a new test addresses a meaningful bottleneck in the diagnostic pathway. In medtech, observation or in-depth interviews can show how a device fits into clinical workflow, training requirements and hospital purchasing procedures.

After launch, HCP research is often used to evaluate brand awareness, message recall, product experience, barriers to adoption and competitive positioning. In a therapy area with multiple treatment options, a quantitative survey may estimate the relative importance of efficacy, safety, route of administration, monitoring burden, access conditions and patient preferences in treatment choice. Qualitative follow-up can then explain why these factors matter in specific clinical situations.

Typical applications of HCP research include:

  • testing communication materials intended for physicians, pharmacists or nurses;
  • mapping referral and treatment pathways across specialties;
  • exploring reasons for delayed diagnosis or delayed treatment initiation;
  • measuring satisfaction with a device, platform, support programme or supplier;
  • identifying differences between public and private healthcare settings;
  • supporting market access and pricing research by understanding perceived value and evidence expectations;
  • tracking changes in professional sentiment following new guidelines, competitor launches or reimbursement decisions.


Hume’s Institute applies HCP research in quantitative, qualitative and mixed-methods projects when decisions require both measurable market evidence and a clear understanding of professional reasoning. The method is particularly useful where a healthcare market cannot be interpreted solely through sales data or patient declarations.

Healthcare professional (HCP) research and related methods

Healthcare professional research is closely connected with several other research methods, but it should not be treated as interchangeable with them. The main distinction concerns the unit of analysis: HCP research focuses on professional stakeholders, whereas other approaches may focus on patients, organisations, observed behaviour or secondary data.

Patient research examines experiences, preferences, outcomes and barriers from the patient perspective. It can reveal concerns about symptoms, treatment burden, communication or access to care. HCP research may identify different priorities, such as diagnostic certainty, guideline alignment, safety monitoring or administrative feasibility. Combining both perspectives helps detect gaps between clinical intent and patient experience.

Healthcare professional research also differs from clinical trials and real-world evidence studies. Clinical trials assess the safety and efficacy of interventions under a defined protocol. Real-world evidence is clinical evidence generated from the analysis of real-world data, such as routinely collected healthcare data, and may examine outcomes, utilisation or treatment patterns. HCP research investigates beliefs, perceptions, intentions and decision logic. These approaches can complement one another, but they answer different questions.

Common methodological formats used in HCP research include:

  • quantitative online or telephone surveys for measurement, segmentation and comparison between groups;
  • in-depth interviews for exploring clinical reasoning, language and unmet needs;
  • focus groups or online communities for discussion of concepts, pathways and communication;
  • conjoint analysis or discrete choice experiments for evaluating trade-offs between product attributes;
  • mixed-methods designs that use qualitative findings to develop a survey and interpret quantitative results;
  • desk research and secondary-data analysis to place primary findings within a regulatory, epidemiological or market context.


The choice of method should reflect the decision to be made. If the question is how often a barrier occurs, quantitative HCP research is usually required. If the question is why a professional does not adopt a clinically relevant innovation, qualitative exploration is often the more appropriate starting point. When both scale and explanation are necessary, a mixed-methods design provides stronger evidence.

How to recruit healthcare professionals for market research

Recruitment is one of the most demanding parts of HCP research because healthcare professionals have limited time, varied eligibility profiles and strict professional obligations. A valid sample requires more than confirming job title. Screening should verify specialty, seniority, practice setting, patient volume where relevant, involvement in treatment or purchasing decisions, and experience with the category being studied.

The question of how to recruit physicians for market research should be approached as a quality-control issue rather than a purely operational task. Recruitment channels may include validated HCP panels, professional networks, specialist associations, healthcare facilities and direct outreach, subject to applicable data-protection, ethics and local compliance requirements. The selected channel should fit the target group. Rare-disease specialists, hospital procurement stakeholders and community pharmacists, for example, require different recruitment strategies.

High-quality healthcare professional research also requires transparent respondent communication. Participants should understand the research purpose, expected time commitment, confidentiality rules and any incentive conditions. Incentives must be appropriate, proportionate and compliant with relevant industry standards. It is equally important to avoid leading questions, promotional framing and any suggestion that participation is connected to prescribing, procurement or patient-care expectations.

Data quality checks should assess whether respondents meet screening criteria, provide consistent answers and demonstrate relevant engagement with the topic. In qualitative projects, moderator expertise matters because the discussion must respect clinical terminology while remaining focused on the research objective. In quantitative HCP research, questionnaire length, terminology and routing should be tailored to professional workflows to reduce respondent burden and improve data reliability.